Corinne Faivre-Finn

Summary

Affiliation: Christie Hospital
Country: UK

Publications

  1. ncbi request reprint Thoracic radiation therapy for limited-stage small-cell lung cancer: unanswered questions
    Corinne Faivre-Finn
    Clinical Oncology Department, Christie Hospital NHS Trust, Wilmslow Road, Withington, Manchester M20 4BX, UK
    Clin Lung Cancer 7:23-9. 2005
  2. doi request reprint Use of G-CSF during concurrent chemotherapy and thoracic radiotherapy in patients with limited-stage small-cell lung cancer safety data from a phase II trial
    Hamid Sheikh
    Dept of Clinical Oncology, the Christie NHS Foundation Trust, Manchester, UK
    Lung Cancer 74:75-9. 2011
  3. ncbi request reprint Thoracic radiotherapy for limited-stage small-cell lung cancer: controversies and future developments
    C Faivre-Finn
    Clinical Oncology Department, Christie Hospital NHS Trust, Manchester, UK
    Clin Oncol (R Coll Radiol) 17:591-8. 2005
  4. doi request reprint Omitting elective nodal irradiation during thoracic irradiation in limited-stage small cell lung cancer--evidence from a phase II trial
    Rovel Colaco
    Department of Clinical Oncology, the Christie NHS Foundation Trust, Manchester, UK
    Lung Cancer 76:72-7. 2012
  5. ncbi request reprint Sequential platinum-based chemotherapy-thoracic radiotherapy in early stage non-small cell lung cancer
    Nick Thatcher
    CRC Department of Medical Oncology, Christie Hospital NHS Trust, Wilmslow Road, Manchester M20 9BX, United Kingdom
    Clin Cancer Res 11:5051s-5056s. 2005
  6. ncbi request reprint Modern management of small-cell lung cancer
    Roberta Ferraldeschi
    Christie Hospital NHS Foundation Trust, Manchester, UK
    Drugs 67:2135-52. 2007
  7. doi request reprint Management of small cell lung cancer: recent developments for optimal care
    Raffaele Califano
    Department of Medical Oncology, the Christie NHS Foundation Trust, Manchester, UK
    Drugs 72:471-90. 2012
  8. doi request reprint Management of unresectable stage III non-small-cell lung cancer with combined-modality therapy: a review of the current literature and recommendations for treatment
    Neil A Bayman
    Department of Clinical Oncology, Christie Hospital, Manchester, UK
    Clin Lung Cancer 9:92-101. 2008
  9. doi request reprint Treatment of limited small cell lung cancer: an old or new challenge?
    Fiona Blackhall
    Department of Medical Oncology, the Christie NHS Foundation Trust, Manchester, UK
    Curr Opin Oncol 23:158-62. 2011
  10. pmc Protocol for the isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC): a feasibility study
    Kate Haslett
    Radiotherapy Related Research, the Christie NHS Foundation Trust, Manchester, UK
    BMJ Open 6:e010457. 2016

Collaborators

Detail Information

Publications17

  1. ncbi request reprint Thoracic radiation therapy for limited-stage small-cell lung cancer: unanswered questions
    Corinne Faivre-Finn
    Clinical Oncology Department, Christie Hospital NHS Trust, Wilmslow Road, Withington, Manchester M20 4BX, UK
    Clin Lung Cancer 7:23-9. 2005
    ..These trials should integrate translational research studies to investigate the molecular basis of RT resistance and to develop biomarker profiles of prognosis...
  2. doi request reprint Use of G-CSF during concurrent chemotherapy and thoracic radiotherapy in patients with limited-stage small-cell lung cancer safety data from a phase II trial
    Hamid Sheikh
    Dept of Clinical Oncology, the Christie NHS Foundation Trust, Manchester, UK
    Lung Cancer 74:75-9. 2011
    ....
  3. ncbi request reprint Thoracic radiotherapy for limited-stage small-cell lung cancer: controversies and future developments
    C Faivre-Finn
    Clinical Oncology Department, Christie Hospital NHS Trust, Manchester, UK
    Clin Oncol (R Coll Radiol) 17:591-8. 2005
    ..This review highlights the need for well-designed multi-national trials aimed at the optimisation and standardisation of radiotherapy for LD SCLC...
  4. doi request reprint Omitting elective nodal irradiation during thoracic irradiation in limited-stage small cell lung cancer--evidence from a phase II trial
    Rovel Colaco
    Department of Clinical Oncology, the Christie NHS Foundation Trust, Manchester, UK
    Lung Cancer 76:72-7. 2012
    ..Routine ENI omission will be further evaluated prospectively in the ongoing phase III CONVERT trial (NCT00433563)...
  5. ncbi request reprint Sequential platinum-based chemotherapy-thoracic radiotherapy in early stage non-small cell lung cancer
    Nick Thatcher
    CRC Department of Medical Oncology, Christie Hospital NHS Trust, Wilmslow Road, Manchester M20 9BX, United Kingdom
    Clin Cancer Res 11:5051s-5056s. 2005
    ....
  6. ncbi request reprint Modern management of small-cell lung cancer
    Roberta Ferraldeschi
    Christie Hospital NHS Foundation Trust, Manchester, UK
    Drugs 67:2135-52. 2007
    ..The challenge for the future is to identify new targets, overcome drug-resistance mechanisms and redundancy in biological systems, and incorporate these new treatments into concurrent chemo-radiotherapy schedules...
  7. doi request reprint Management of small cell lung cancer: recent developments for optimal care
    Raffaele Califano
    Department of Medical Oncology, the Christie NHS Foundation Trust, Manchester, UK
    Drugs 72:471-90. 2012
    ..Ongoing trials will shed some light on the impact of thoracic radiotherapy on QOL, symptom control and survival in ED SCLC patients who benefitted from first-line chemotherapy...
  8. doi request reprint Management of unresectable stage III non-small-cell lung cancer with combined-modality therapy: a review of the current literature and recommendations for treatment
    Neil A Bayman
    Department of Clinical Oncology, Christie Hospital, Manchester, UK
    Clin Lung Cancer 9:92-101. 2008
    ..The potential role of novel and targeted therapies and radiation dose escalation is also considered. Finally, recommendations are made for the treatment of unresectable stage III NSCLC...
  9. doi request reprint Treatment of limited small cell lung cancer: an old or new challenge?
    Fiona Blackhall
    Department of Medical Oncology, the Christie NHS Foundation Trust, Manchester, UK
    Curr Opin Oncol 23:158-62. 2011
    ..This review highlights how progress has been made in treating limited small cell lung cancer and outlines current challenges to overcome for improved cure rates...
  10. pmc Protocol for the isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC): a feasibility study
    Kate Haslett
    Radiotherapy Related Research, the Christie NHS Foundation Trust, Manchester, UK
    BMJ Open 6:e010457. 2016
    ..This study aims to evaluate whether delivering isotoxic radiotherapy using intensity modulated radiotherapy (IMRT) is achievable...
  11. doi request reprint How can we optimise concurrent chemoradiotherapy for inoperable stage III non-small cell lung cancer?
    Neil Bayman
    Department of Clinical Oncology, the Christie NHS Foundation Trust, Manchester, UK
    Lung Cancer 83:117-25. 2014
    ....
  12. doi request reprint Lung cancer after treatment for breast cancer
    Paul Lorigan
    Cancer Research UK Department of Medical Oncology, the Christie NHS Foundation Trust, Manchester, UK
    Lancet Oncol 11:1184-92. 2010
    ..Adjuvant chemotherapy is not significantly associated with an increased risk. The risk of developing lung cancer increases with time elapsed since treatment, but any effect of age at treatment is unclear...
  13. pmc Protocol for the CONVERT trial-Concurrent ONce-daily VErsus twice-daily RadioTherapy: an international 2-arm randomised controlled trial of concurrent chemoradiotherapy comparing twice-daily and once-daily radiotherapy schedules in patients with limited s
    Corinne Faivre-Finn
    Manchester Academic Health Science Centre, Institute of Cancer Sciences, Manchester Cancer Research Centre MCRC, The University of Manchester, Manchester, UK Radiotherapy Related Research, the Christie NHS Foundation Trust, Manchester, UK
    BMJ Open 6:e009849. 2016
    ..This trial has the potential to define a new standard chemo-RT regimen for patients with LS-SCLC and good performance status...
  14. doi request reprint Targeted agents in non-small cell lung cancer (NSCLC): clinical developments and rationale for the combination with thoracic radiotherapy
    Pek Keng Koh
    Department of Clinical Oncology, the Christie NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK
    Cancer Treat Rev 38:626-40. 2012
    ..Here we summarise the progress made to date and highlight future directions...
  15. pmc Early reduction in tumour [18F]fluorothymidine (FLT) uptake in patients with non-small cell lung cancer (NSCLC) treated with radiotherapy alone
    Ioannis Trigonis
    Institute of Population Health, Wolfson Molecular Imaging Centre, Manchester Academic Health Sciences Centre, The University of Manchester, Manchester, M20 3LJ, UK
    Eur J Nucl Med Mol Imaging 41:682-93. 2014
    ..The aim of this study was to assess whether FLT changes occur early in response to radiotherapy (RT) without concurrent chemotherapy and whether such changes exceed test-retest variability...
  16. doi request reprint Prophylactic radiotherapy to intervention sites in mesothelioma: a systematic review and survey of UK practice
    Caroline Lee
    Department of Clinical Oncology, Christie Hospital NHS Trust, Wilmslow Road, Manchester M20 4BX, UK
    Lung Cancer 66:150-6. 2009
    ..This is believed to be reduced by the common practice of prophylactic irradiation to intervention tracts (PIT). However, evidence to support PIT is currently inadequate and contentious...
  17. ncbi request reprint Prophylactic cranial irradiation in extensive small-cell lung cancer
    Ben Slotman
    Department of Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands
    N Engl J Med 357:664-72. 2007
    ..We conducted a randomized trial of prophylactic cranial irradiation in patients with extensive small-cell lung cancer who had had a response to chemotherapy...